These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 39038094)
1. Trends in Black-White Differences of Antihypertensive Treatment in Individuals With and Without History of Stroke. Stamm B; Royan R; Cui J; Long DL; Lineback CM; Akinyelure OP; Plante TB; Levine DA; Howard VJ; Howard G; Gorelick PB Stroke; 2024 Aug; 55(8):2034-2044. PubMed ID: 39038094 [TBL] [Abstract][Full Text] [Related]
2. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report. Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191 [TBL] [Abstract][Full Text] [Related]
3. First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care. Sinnott SJ; Douglas IJ; Smeeth L; Williamson E; Tomlinson LA BMJ; 2020 Nov; 371():m4080. PubMed ID: 33208355 [TBL] [Abstract][Full Text] [Related]
4. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. Wright JT; Dunn JK; Cutler JA; Davis BR; Cushman WC; Ford CE; Haywood LJ; Leenen FH; Margolis KL; Papademetriou V; Probstfield JL; Whelton PK; Habib GB; JAMA; 2005 Apr; 293(13):1595-608. PubMed ID: 15811979 [TBL] [Abstract][Full Text] [Related]
5. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention. Talbert RL J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609 [TBL] [Abstract][Full Text] [Related]
6. Sex and Race Differences in the Association of Incident Ischemic Stroke With Risk Factors. Howard VJ; Madsen TE; Kleindorfer DO; Judd SE; Rhodes JD; Soliman EZ; Kissela BM; Safford MM; Moy CS; McClure LA; Howard G; Cushman M JAMA Neurol; 2019 Feb; 76(2):179-186. PubMed ID: 30535250 [TBL] [Abstract][Full Text] [Related]
7. Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Bajaj NS; Gutiérrez OM; Arora G; Judd SE; Patel N; Bennett A; Prabhu SD; Howard G; Howard VJ; Cushman M; Arora P JAMA Cardiol; 2018 Jan; 3(1):11-17. PubMed ID: 29167879 [TBL] [Abstract][Full Text] [Related]
8. Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks. Bangalore S; Ogedegbe G; Gyamfi J; Guo Y; Roy J; Goldfeld K; Torgersen C; Capponi L; Phillips C; Shah NR Am J Med; 2015 Nov; 128(11):1195-203. PubMed ID: 26071821 [TBL] [Abstract][Full Text] [Related]
9. Trends in Antihypertensive Medication Use Among Individuals With a History of Stroke and Hypertension, 2005 to 2016. Santos D; Dhamoon MS JAMA Neurol; 2020 Nov; 77(11):1382-1389. PubMed ID: 32716495 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin Receptor Blockers for Hypertension and Risk of Epilepsy. Wen X; Otoo MN; Tang J; Brothers T; Ward KE; Asal N; Meador KJ JAMA Neurol; 2024 Aug; 81(8):866-874. PubMed ID: 38884986 [TBL] [Abstract][Full Text] [Related]
11. Gene Variants at Loci Related to Blood Pressure Account for Variation in Response to Antihypertensive Drugs Between Black and White Individuals. Iniesta R; Campbell D; Venturini C; Faconti L; Singh S; Irvin MR; Cooper-DeHoff RM; Johnson JA; Turner ST; Arnett DK; Weale ME; Warren H; Munroe PB; Cruickshank K; Padmanabhan S; Lewis C; Chowienczyk P Hypertension; 2019 Sep; 74(3):614-622. PubMed ID: 31327267 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive medications and C-reactive protein in the multi-ethnic study of atherosclerosis. Palmas W; Ma S; Psaty B; Goff DC; Darwin C; Barr RG Am J Hypertens; 2007 Mar; 20(3):233-41. PubMed ID: 17324732 [TBL] [Abstract][Full Text] [Related]
13. Associations between birth weight and antihypertensive medication in black and white medicaid recipients. Lackland DT; Egan BM; Syddall HE; Barker DJ Hypertension; 2002 Jan; 39(1):179-83. PubMed ID: 11799099 [TBL] [Abstract][Full Text] [Related]
14. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154 [TBL] [Abstract][Full Text] [Related]
15. Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatment. Dickson M; Plauschinat CA Ethn Dis; 2008; 18(2):204-9. PubMed ID: 18507275 [TBL] [Abstract][Full Text] [Related]
16. Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN). Jackson EA; Ruppert K; Derby CA; Lian Y; Neal-Perry G; Habel LA; Tepper PG; Harlow SD; Solomon DH J Am Heart Assoc; 2017 Feb; 6(3):. PubMed ID: 28232324 [TBL] [Abstract][Full Text] [Related]
17. Neighborhood Factors, Individual Stressors, and Cardiovascular Health Among Black and White Adults in the US: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Hines AL; Albert MA; Blair JP; Crews DC; Cooper LA; Long DL; Carson AP JAMA Netw Open; 2023 Sep; 6(9):e2336207. PubMed ID: 37773494 [TBL] [Abstract][Full Text] [Related]
18. Prescribing pattern of antihypertensive drugs by family physicians and general practitioners in the primary care setting in Bahrain. Sequeira RP; Jassim KA; Damanhori AH; Mathur VS J Eval Clin Pract; 2002 Nov; 8(4):407-14. PubMed ID: 12421390 [TBL] [Abstract][Full Text] [Related]